Ventrix
Solutions For The Heart
Solutions For The Heart
Ventrix is a biotechnology startup with a mission to provide solutions for the heart, focusing on delivering a biomaterial scaffold for cardiac repair for heart attack patients. Established in 2009 and headquartered in San Diego, CA, Ventrix closed a Series A financing round in 2012, receiving funding from NIH and NSF SBIR awards. The company's last investment was a $5.16M Convertible Note investment in May 31, 2012. Ventrix is open to partnership opportunities with leading Healthcare Technology companies and invites those interested in collaboration or investment to reach out. With a strong foothold in the industry, Ventrix presents an exciting investment prospect for those looking to support cutting-edge advancements in biotechnology and healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Convertible Note | $5.16M | - | 31 May 2012 | |
| Debt Financing | $147.00K | - | 16 Jul 2010 |
No recent news or press coverage available for Ventrix.
We care about your data, and we'd love to use cookies make your experience better.
